Hyaluronic Acid Dermal Filler: Complete Guide
A hyaluronic acid dermal filler is not one product but a family of gels whose behaviour is set by four manufacturing decisions: how much HA is in the syringe, how heavily it is cross-linked, whether the gel is monophasic or biphasic, and what particle size results. Two fillers can share the same indication, the same 20 mg/mL label and completely different mechanical behaviour, which is why "HA filler" is a category rather than a specification.
This guide is written for practitioners, clinic owners, distributors and OEM buyers who need to compare products on properties rather than on marketing claims. It covers the chemistry that determines performance, the six measurements that describe a gel, how particle size maps to injection plane, and the documentation to request before an order. It is a technical reference, not a treatment protocol.
Key takeaways
• An HA filler is a hydrogel: cross-linked HA suspended in a buffered vehicle. The label concentration counts both the cross-linked and the free fraction.
• Cross-linking is what makes unmodified HA — which the body clears within hours to days — last for months.
• Concentration is not strength. A 20 mg/mL gel can be soft or firm depending on cross-link density, not on how many milligrams are printed on the box.
• G′, cohesivity and particle size predict lift, spread and plane far better than concentration alone.
• HA fillers are the one family that can be dissolved with hyaluronidase — a reversibility property no other filler class shares.
In this guide
What an HA filler is · Why cross-linking exists · Cross-linkers and residue · Monophasic vs biphasic
The six measurements · Concentration vs cross-linking · Particle size and plane · Degradation and duration
Safety and reversibility · Procurement specification · The AuroThread HA range · Specifications by SKU · FAQ
What an HA Filler Actually Is
A hyaluronic acid filler is a hydrogel: a three-dimensional network of cross-linked HA chains swollen with water, suspended in a physiological or phosphate-buffered vehicle. The polymer is not dissolved in the way sugar dissolves in water — it holds water inside a structure, and that structure is what resists compression once placed in tissue.
The HA itself is a polysaccharide the body already produces, present in skin, connective tissue and synovial fluid. Commercial filler HA is manufactured either from avian tissue or, in most modern products, by bacterial fermentation, which reduces residual protein and therefore allergenic potential. Fundarò et al. note that HA fillers now account for roughly 80% of all fillers used for facial rejuvenation and volume correction — a figure that explains both the depth of the category and how easily products get treated as interchangeable.
For a buyer, the practical consequence is that a specification built only on "hyaluronic acid" plus a concentration tells you almost nothing. The material family is a starting point; the engineering is the product.
Why Cross-Linking Exists
Native, unmodified HA has a short half-life in tissue. It is degraded rapidly by hyaluronidase and by chemical and enzymatic hydrolysis, which is why an uncross-linked HA solution cannot hold volume for long enough to be useful as a filler.
Cross-linking solves this by bridging polymer chains to one another, converting a viscous liquid into a viscoelastic gel. The clinical consequence is twofold. First, the gel resists enzymatic breakdown longer. Second, the network creates a steric barrier that slows the penetration and mobility of hyaluronidase inside it — the filler is not merely harder to digest, it is harder for the enzyme to reach.
The degree of cross-linking also determines how "hard" the gel becomes. Increasing it raises rigidity, and at the upper end the material approaches a solid. This is the single most important manufacturing lever for matching a product to a tissue plane: fine lines need a soft, spreading gel, while deep volume restoration needs a firmer gel that lifts and stays where it is placed.
Cross-Linkers, and Why Residue Is Regulated
The most widely used cross-linker is BDDE (1,4-butanediol diglycidyl ether), which forms irreversible covalent bonds between HA chains. Alternatives exist — DEO, divinyl sulfone, HMDA and PEGDE among them — but BDDE dominates because it produces a stable network, degrades predictably and has a comparatively well-characterised safety profile.
The manufacturing consequence is that not all BDDE reacts. A fraction remains unbound, and because the molecule is not inert, regulators cap the residual amount permitted in the finished device. Every credible manufacturer therefore runs a purification step and states the residual level in the technical file.
This is one of the few places where a buyer can distinguish a documented product from an undocumented one at almost no cost: ask for the residual cross-linker figure and the method used to measure it. A supplier who cannot produce that number has not finished the specification, regardless of how the product photographs.
AuroThread states BDDE residual below the applicable regulatory threshold for the Auro Secret range, alongside CE marking, ISO 13485 and GMP manufacturing. The clause "below threshold" is a compliance statement rather than a measurement — if you need the analytical figure for a tender or registration file, request it explicitly.
Monophasic Versus Biphasic Gels
Two HA fillers can be approved for the same indication and behave differently because they are built differently. The dividing line is whether the gel is monophasic or biphasic — sometimes described as cohesive versus granular.
| Property | Monophasic (cohesive) | Biphasic (granular) |
|---|---|---|
| Structure | Homogeneous blend of cross-linked chains | Cross-linked particles dispersed in a fluid vehicle |
| Elasticity vs viscosity | Generally lower elasticity, higher viscosity | Generally higher elasticity |
| Behaviour in tissue | Integrates as one continuous mass | Particles remain discrete within the vehicle |
| Batch consistency to verify | Extrusion force and gel homogeneity | Particle size distribution and sieve fraction |
Neither architecture is better in the abstract. The point for a buyer is that the architecture should be stated on the specification, because it determines which batch parameters the certificate of analysis has to control. A supplier who cannot say whether the product is monophasic or biphasic is not controlling the variable that most affects behaviour.
Comparing HA grades for a formulary? The AuroThread technical file states HA concentration, particle size and count per mL, needle and cannula compatibility, cross-linker, residual monomer control, sterilisation method and certification for each grade.
The Six Measurements That Describe a Gel
Rheology is how the category becomes comparable. Six measurements appear repeatedly in the filler literature because each one predicts something a clinician or a buyer needs to know.
| Measurement | What it describes | What it predicts |
|---|---|---|
| G′ storage modulus | Energy stored during deformation; the gel’s ability to recover shape | Lift and projection — higher G′ holds shape against load |
| G″ loss modulus | Energy lost to internal friction; incomplete recovery | Flow and spread under movement |
| tan δ (G″/G′) | Balance of viscous to elastic behaviour | Whether the gel behaves more like a solid or a liquid |
| Cohesivity | Internal adhesion holding cross-linked units together | Resistance to compression and stretching; tendency to remain one mass |
| η* complex viscosity | Resistance to deformation under shear; “thickness” | Extrusion force — how the product behaves through a needle or cannula |
| Swelling ratio | Water uptake capacity per unit of polymer | Post-injection volume change and expected swelling |
Read together, these values let you place a product without injecting it. A high G′ with high cohesivity describes a lifting gel for deep placement. A low G′ with high η* describes something that spreads and extrudes easily — a superficial gel. Two products labelled 20 mg/mL can sit at opposite ends of that spectrum.
Concentration Versus Cross-Linking
The number most often quoted in a sales conversation is HA concentration in mg/mL. It is worth knowing precisely what that number contains: both the cross-linked, insoluble fraction and the free, soluble fraction. Only the insoluble part provides a long-lasting presence in tissue; the soluble part is metabolised quickly.
This is why concentration alone cannot predict duration. A product can reach 20 mg/mL with a large free fraction and a small cross-linked network, or with the reverse. The two behave nothing alike, yet print the same figure on the box.
The AuroThread HA grades are stated at 20 mg/mL for Fine, Derm and Deep. Because concentration is held constant across those three, the differentiator between them is particle size and particle count — not concentration. That is a deliberate design choice, and it is a more honest way to describe a range than quoting a single strength figure and implying that the grade is the variable.
When a supplier quotes concentration as the headline specification, ask two follow-ups: what proportion is cross-linked, and what is the particle count per millilitre? Those two answers do more to characterise the product than any single number.
Particle Size and the Injection Plane
Particle size is the parameter that connects a product to an anatomical plane. Smaller particles spread and sit superficially; larger particles resist displacement and belong deeper. Particle count moves in the opposite direction — the finer the particles, the more of them fit into a millilitre.
| Grade | Particle size | Particles per mL | Needle | Plane |
|---|---|---|---|---|
| Fine | 0.10–0.15 mm | 200,000 | 27G | Upper dermis |
| Derm | 0.15–0.28 mm | 100,000 | 27G | Mid dermis |
| Deep | 0.28–0.50 mm | 10,000 | 26G | Deep dermis |
| Subskin | 0.5–1.25 mm | 5,000 | 22G–30G cannula options | Subcutaneous / body planes |
The pattern is worth remembering as a rule of thumb: particle size and count move in opposite directions, and the pair tells you where the product belongs. Fine carries 200,000 particles per mL at 0.10–0.15 mm; Derm carries half that count at roughly double the particle size; Subskin carries a fortieth of Fine’s count at up to eight times the size.
Need rheology values for a tender or registration file? AuroThread supplies grade-level technical documentation — HA concentration, particle metrics, cross-linker and residual control, sterilisation, and certification scope — and can state which parameters are measured per batch.
Degradation, and the Three Duration Numbers
HA degrades through enzymatic and chemical hydrolysis, and the cross-linked network slows both. Degradation is also why the material is considered temporary: the gel is progressively broken down and the water it held disperses.
Three legitimate figures
Three different figures legitimately describe the same product, and mixing them is the most common source of specification drift:
| Figure | What it describes | Who states it |
|---|---|---|
| Material-class figure | A regulator’s summary across the approved products in a class | The FDA, describing HA fillers as lasting approximately 6 to 12 months |
| Manufacturer specification | The stated range for a specific grade, under stated conditions | The product’s technical file |
| Observed outcome | What a particular patient experienced | Clinical records — not a product claim |
AuroThread states 6–18 months across the HA grade pages. That is a manufacturer specification and should be read as one: it is broader than the regulatory class figure because it spans four grades with different particle sizes, not because the material behaves differently from other HA.
Safety, and the Property No Other Filler Has
Regulation and approved indications
Dermal fillers are regulated as medical devices, not drugs, and the FDA has approved HA fillers for defined facial indications in people aged 22 and older — correcting moderate-to-severe facial wrinkles and folds, increasing fullness of lips, cheeks, chin, under-eye hollows and jawline, and restoring facial fat loss in specific patient groups. The same regulator states plainly that injectable fillers are not approved for body contouring, including the buttocks and breasts.
Reversibility
The property that separates HA from every other filler family is reversibility. Because the material is HA, it can be broken down with hyaluronidase. Calcium hydroxylapatite, PLLA and PMMA cannot be dissolved in the same way, which makes the choice of material a decision about exit options as well as about results.
Reported risks
Reported risks follow the injection, not the brand. The FDA’s patient guidance groups them the same way: bruising, redness, swelling, pain and tenderness are common; nodules, granulomas, infection and allergic reaction are less common; and unintended intravascular injection is the serious one, with outcomes that include skin necrosis, stroke and blindness. Product quality affects the rate of some of these; technique affects others. Neither substitutes for the other. The full safety section in the pillar guide sets out the FDA’s risk categories in more detail.
The HA Procurement Specification
Because the material family tells you so little, the specification has to carry the weight. Eight items separate a documented HA filler from a photographed one.
| Item | What to ask for |
|---|---|
| 1. HA concentration | mg/mL, and the split between cross-linked and free fraction |
| 2. Cross-linker | Identity (typically BDDE) and residual level with the test method |
| 3. Architecture | Monophasic or biphasic; particle size distribution if granular |
| 4. Particle metrics | Size range in mm and count per mL, per grade |
| 5. Rheology | G′ and extrusion force, if the supplier measures them |
| 6. Sterilisation | Method and validation, plus packaging format |
| 7. Certification | CE certificate with classification and notified body; ISO 13485 with scope and validity |
| 8. Batch release | Lot-linked certificate of analysis, traceable to the syringe |
The AuroThread HA Range
AuroThread manufactures cross-linked HA fillers in four particle bands, supplied in 1 mL, 2 mL, 3 mL and 10 mL formats, individually packaged, with 27G–30G needles and 22G–30G blunt cannulas. The range is CE marked, made under ISO 13485 and GMP, and sterilised by a terminal moist-heat process on the Auro Secret Plus line.
The four grades map onto the plane ladder described above: Fine for the upper dermis, Derm for the mid dermis, Deep for deep placement, Subskin for subcutaneous and body planes. For a clinic building a formulary, that is a four-SKU ladder rather than a single hero product — which is what most aesthetic practices actually need to cover the zones they treat. The plain-language explanation of HA fillers covers the same range from a patient-facing angle.
Specifications by SKU
Fine
0.10–0.15 mm · 200,000 particles/mL · 27G · upper dermis
The finest graded HA in the range, used where the overlying skin is thin and the plane shallow.
View Product
Derm
0.15–0.28 mm · 100,000 particles/mL · 27G · mid dermis
The middle band, specified for folds and lines where a little more support is needed than Fine provides.
View Product
Deep
0.28–0.50 mm · 10,000 particles/mL · 26G · deep dermis
A larger-particle HA for mid-cheek, temple and jawline support where the plane sits deeper.
View Product
Subskin
0.5–1.25 mm · 5,000 particles/mL · cannula options
The coarsest grade, specified for the deepest plane and for subcutaneous volume.
View ProductFor the non-cross-linked option used in skin-quality work, see the non-cross-linked hyaluronic acid grade, and for the collection view see Auro Secret hyaluronic acid fillers.
Where to Read Next
Dermal fillers: the complete guide — the topic hub, covering every material family and the safety profile.
What are dermal fillers made of? — HA set against CaHA, PLLA and PMMA.
Types of dermal fillers — the regulatory taxonomy behind the category.
How do dermal fillers work? — mechanism, plane by plane.
Facial fillers: complete overview — which grade goes where, by zone.
Injectable fillers: a practitioner overview — procurement across all four families.
Frequently asked questions
Is hyaluronic acid dermal filler the same as hyaluronic acid serum?
No. A serum is a topical cosmetic that hydrates the surface of the skin. A filler is a cross-linked gel injected into a tissue plane, and it is regulated as a medical device rather than a cosmetic. The raw material overlaps; the product, the regulation and the effect do not.
Does a higher HA concentration mean a longer-lasting filler?
Not on its own. Duration depends on the cross-linked fraction, the degree of cross-linking, particle size and the plane injected. A gel can carry a high concentration with a large free, rapidly metabolised fraction. Ask for the cross-linked proportion, not just the mg/mL figure.
What is the difference between monophasic and biphasic HA fillers?
A monophasic gel is a homogeneous blend of cross-linked chains. A biphasic gel suspends cross-linked particles in a fluid vehicle. Monophasic gels generally show lower elasticity and higher viscosity; biphasic gels generally show higher elasticity. The behaviour differs even when the approved indication is identical.
Why is BDDE residue regulated?
BDDE is the cross-linker, and not all of it reacts during manufacture. A fraction remains unbound, so purification is required and regulators cap the residual amount permitted in the finished device. Ask the supplier for the residual figure and the analytical method used.
How long do hyaluronic acid fillers last?
The FDA describes HA fillers as lasting approximately 6 to 12 months. AuroThread specifies 6–18 months across its four HA grades, which reflects differing particle sizes rather than a different material. Individual outcomes vary with plane, volume and patient factors.
Can hyaluronic acid filler be dissolved?
Yes. HA can be broken down with hyaluronidase, which is the reversibility property that distinguishes it from calcium hydroxylapatite, PLLA and PMMA. That is a clinical decision made by the treating practitioner, not a product feature that guarantees a specific outcome.
What does particle size per millilitre tell a buyer?
Particle size and particle count move in opposite directions. Fine carries 200,000 particles per mL at 0.10–0.15 mm; Subskin carries 5,000 per mL at 0.5–1.25 mm. Together they indicate which plane the product is designed for and how it will behave under load.
Is HA filler approved for body contouring?
No. The FDA states that injectable fillers are not approved for body contouring, including use in the buttocks and breasts, and warns that such use has caused serious injury. Approved facial indications are specific and should be stated in the technical documentation.
Do all AuroThread HA grades contain lidocaine?
Lidocaine content varies by product and is not stated uniformly across the grade pages, so it should be confirmed against the specification for the specific SKU rather than assumed across the range. Request the concentration in mg/mL if the formulation includes it.
What certifications should accompany an HA filler order?
A CE certificate stating the device classification and notified body, an ISO 13485 certificate with scope and validity dates, and a lot-linked certificate of analysis traceable to the syringes supplied. Auro Secret is CE marked and manufactured under ISO 13485 and GMP.
Which HA grade should a clinic start with?
It depends on which zones the practice treats. A four-grade ladder covers superficial lines through to subcutaneous volume; a practice restricted to superficial work may only need the finer bands. The area-based guide maps zones to grades as a starting point.
